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Background: Cardiac Magnetic Resonance (CMR) can distinguish ischemic (ICM) vs non- ischemic cardiomyopathy (NICM) with very high 
sensitivity based on the presence and distribution of fibrosis. The absence of scar in patients with severely reduced left ventricular ejection 
fraction (LVEF) and non-obstructive coronary artery disease (CAD) is specific for NICM. Coronary artery bypass grafting (CABG) in patients 
with 3-vessel CAD with reduced LVEF and no scar detected by CMR poses a clinical challenge.
methods: Sixty-four patients from 5 centers, who had LVEF ≤35 % on CMR prior to CABG and underwent LVEF reassessment within 1 
year post CABG. Patients were divided into 5 groups: 1. No scar (n = 6) 2. Viable myocardium (n = 43) 3. Non-viable myocardium (n = 
9) 4. Non-ischemic scar (n = 3), 5. Combined ICM and NICM scar pattern (n = 3). We defined a non-viable group as the presence of ≥5 
segments with ≥ 50% scar. The outcome was change in the LVEF.
results: There were no differences in baseline characteristics and LVEF between groups. The mean LVEF increased 6 % in group 1, 10 
% in group 2, 4% in group 3, 21% in group 4,and 11 % in group 5. There was no statistically significant difference between patients with no 
scar and the other groups. In Group 1, 66% of patients had an improvement in LVEF (mean 15%) compared to 81% in the other 4 groups 
(mean 13%).
conclusion: Patients with 3-vessel CAD, reduced LVEF and no fibrosis detected by CMR are a heterogeneous population with significant 
differences in recovery of function after revascularization.
